Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on March 10, 2025
4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD
GlobeNewswire
·
March 10, 2025
EMERYVILLE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment …
Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics
GlobeNewswire
·
March 10, 2025
– Symvess is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial replacement and repair – – Publication of the Budget Impact Model in peer-reviewed journal supports Symvess as a …
Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform
GlobeNewswire
·
March 10, 2025
SAN DIEGO, March 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced promising preclinical …
UNITY Biotechnology Appoints Industry Leader and Ophthalmology Expert Yehia Hashad, M.D., to the Board of Directors
GlobeNewswire
·
March 10, 2025
SAN FRANCISCO, March 10, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that Yehia Hashad, M.D., executive vice …
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 10, 2025
SOUTH SAN FRANCISCO, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, …
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate
GlobeNewswire
·
March 10, 2025
The World Health Organization (WHO) recently reaffirmed the spread of new clade Ib Mpox a public health emergency of international concern (PHEIC): second Mpox-related WHO PHEIC declaration in two years Clade Ib Mpox cases detected in several countries in …
Alumis to Present at Leerink's 2025 Global Healthcare Conference
GlobeNewswire
·
March 10, 2025
SOUTH SAN FRANCISCO, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of …
Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform
GlobeNewswire
·
March 10, 2025
Raanana, Israel, March 10, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today the initiation of …
SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea
GlobeNewswire
·
March 10, 2025
TEL AVIV, Israel, March 10, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, …
Cognition Therapeutics to Present at Life Sciences Virtual Investor Conference
GlobeNewswire
·
March 10, 2025
PURCHASE, N.Y., March 10, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing product candidates that treat neurodegenerative disorders, (the “Company” or “Cognition”), …
Veri Medtech (VRHI) Network Grows To 400 Physicians
GlobeNewswire
·
March 10, 2025
NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- Veri Medtech Holdings (OTC Markets: “VRHI”) ("Veri Medtech") announced today that its powerful network of licensed physicians has now grown to 400, forming an Infinite Wellness Loop. “Having a strong network of …
Prelude Therapeutics Reports Full Year 2024 Financial Results and Provides Program Outlook for 2025
GlobeNewswire
·
March 10, 2025
PRT3789 has demonstrated clinical proof-of-concept that selectively degrading SMARCA2 is generally safe and has monotherapy anti-tumor activity in patients with SMARCA4-deficient, non-small cell lung (NSCLC), gastric and esophageal cancer PRT3789 …
Plus Therapeutics Regains Compliance with Nasdaq Minimum Stockholders’ Equity Requirement
GlobeNewswire
·
March 10, 2025
HOUSTON, March 10, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company” or “Plus Therapeutics”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous …
Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea
GlobeNewswire
·
March 10, 2025
Vancouver, Canada, March 10, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion
GlobeNewswire
·
March 10, 2025
CARLSBAD, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the …
Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 10, 2025
Initiated Phase 1 Single Ascending Dose Trial of DT-216P2 in Healthy Volunteers; Friedreich Ataxia (FA) Patient Dosing to Begin in mid-2025 Dosing Complete in DT-168 Phase 1 Healthy Volunteer Trial, with Data on Track for the First Half of 2025; Enrollment …
Kraig Biocraft Laboratories Meets its Target With Largest Ever Product Batch of BAM-1 Spider Silk - Surpassing Entire 2024 Output
GlobeNewswire
·
March 10, 2025
ANN ARBOR, Mich., March 10, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a global leader in engineered spider silk technologies, is thrilled to announce that it has begun production of the largest …
Exposure Consulting's Leading Environmental Scientist Dr. Alex LeBeau Offers Exclusive Media Interviews on the Growing PFAS Crisis
GlobeNewswire
·
March 10, 2025
ORLANDO, Fla., March 10, 2025 (GLOBE NEWSWIRE) -- There is an escalating crisis surrounding per- and polyfluoroalkyl substances (PFAS), also known as “forever chemicals.” This has sparked nationwide concern as new research continues to expose their …
ElevateBio Collaborates with AWS to Broaden the Potential of CRISPR Gene Editing Therapies with Generative AI
GlobeNewswire
·
March 10, 2025
ElevateBio will leverage artificial intelligence to expand and accelerate CRISPR discovery, design, and drug development for thousands of complex monogenic and polygenic diseases Generative AI combined with ElevateBio Life Edit’s immense library of CRISPR …
The Bluffs Addiction Campuses Unveils Special Forces Veteran Kyle Morgan’s Journey of Recovery
GlobeNewswire
·
March 10, 2025
SHERRODSVILLE, Ohio, March 10, 2025 (GLOBE NEWSWIRE) -- The Bluffs Addiction Campuses unveiled the inspiring recovery journey of Kyle Morgan, a retired Special Forces Green Beret and CEO of Blu Bearing Solutions. During a special event on February 28, …